INmune Bio Cash from Financing (TTM) Trends

INmune Bio Inc (INMB)

9.46 -0.08 (-0.79%) USD | NASDAQ | May 31, 16:00

9.475 +0.02 (+0.16%) After-Hours: 20:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2018. Upgrade now.

Date	Value
March 31, 2024	-6.725M
December 31, 2023	-4.225M
September 30, 2023	-1.725M
June 30, 2023	0.00
March 31, 2023	0.00
December 31, 2022	0.729M
September 30, 2022	0.729M
June 30, 2022	53.67M
March 31, 2022	68.62M
December 31, 2021	96.36M
September 30, 2021	96.36M

Date	Value
June 30, 2021	66.66M
March 31, 2021	52.37M
December 31, 2020	23.90M
September 30, 2020	23.90M
June 30, 2020	0.655M
March 31, 2020	4.949M
December 31, 2019	12.21M
September 30, 2019	12.21M
June 30, 2019	12.21M
March 31, 2019	7.251M
December 31, 2018	0.90M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

-6.725M

Minimum

Mar 2024

96.36M

Maximum

Sep 2021

25.64M

Average

12.21M

Median

Jun 2019

Cash from Financing (TTM) Benchmarks